Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites†,‡

2010520 citationsJournal Articlebronze Open Access

Authors

Thomas Sersté · Inserm

Christian Mélot · Université Libre de Bruxelles

Claire Francoz · Inserm

François Durand · Inserm

Pierre‐Emmanuel Rautou · Inserm

Dominique Valla · Inserm

Richard Moreau · Inserm

Abstract

The use of beta-blockers is associated with poor survival in patients with refractory ascites. These results suggest that beta-blockers should be contraindicated in these patients.

Topics & Keywords

Liver Disease and Transplantation Liver Disease Diagnosis and Treatment Organ Transplantation Techniques and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

Volume 52, Issue 3, pp. 1017-1022

DOI: 10.1002/hep.23775

Field-Weighted Citation Impact: 13.21